Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-Δ24-RGD, in anticipation of a phase I trial for recurrent ovarian cancer-Reference-Cited by-同舟云学术

Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-Δ24-RGD, in anticipation of a phase I trial for recurrent ovarian cancer

Published:2007-04 Issue:4 Volume:196 Page:389.e1-389.e10
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Page John G.,Tian Baohong,Schweikart Karen,Tomaszewski Joseph,Harris Ray,Broadt Trevor,Polley-Nelson Judith,Noker Patricia E.,Wang Minghui,Makhija Sharmila,Aurigemma Rose,Curiel David T.,Alvarez Ronald D.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference34 articles.

1. Cancer statistics, 2006;Jemal;CA Cancer J Clin,2006

2. Intraperitoneal cisplatin and paclitaxel in ovarian cancer;Armstrong;N Engl J Med,2006

3. National Cancer Institute clinical announcement,2006

4. Cancer of the ovary;Cannistra;N Engl J Med,2004

5. Conditionally replicative adenoviruses for ovarian cancer therapy;Barnes;Mol Cancer Ther,2002

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer;Cancer Gene Therapy;2020-09-19

2. Defining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agents;Journal of Ovarian Research;2019-02-15

3. Advances in oncolytic adenovirus therapy for pancreatic cancer;Cancer Letters;2018-10

4. Development of Oncolytic Adenoviruses for the Management of Prostate Cancer;Prostate Cancer;2018-09-26

5. Oncolytic adenovirus-mediated therapy for prostate cancer;Oncolytic Virotherapy;2016-07